1. Home
  2. XERS vs SEAT Comparison

XERS vs SEAT Comparison

Compare XERS & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • SEAT
  • Stock Information
  • Founded
  • XERS 2005
  • SEAT 2001
  • Country
  • XERS United States
  • SEAT United States
  • Employees
  • XERS N/A
  • SEAT N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • SEAT Industrial Machinery/Components
  • Sector
  • XERS Health Care
  • SEAT Industrials
  • Exchange
  • XERS Nasdaq
  • SEAT Nasdaq
  • Market Cap
  • XERS 628.7M
  • SEAT 366.2M
  • IPO Year
  • XERS 2018
  • SEAT N/A
  • Fundamental
  • Price
  • XERS $5.16
  • SEAT $1.83
  • Analyst Decision
  • XERS Strong Buy
  • SEAT Buy
  • Analyst Count
  • XERS 5
  • SEAT 11
  • Target Price
  • XERS $6.10
  • SEAT $4.49
  • AVG Volume (30 Days)
  • XERS 2.3M
  • SEAT 2.5M
  • Earning Date
  • XERS 05-08-2025
  • SEAT 05-06-2025
  • Dividend Yield
  • XERS N/A
  • SEAT N/A
  • EPS Growth
  • XERS N/A
  • SEAT N/A
  • EPS
  • XERS N/A
  • SEAT N/A
  • Revenue
  • XERS $222,551,000.00
  • SEAT $748,757,000.00
  • Revenue This Year
  • XERS $31.75
  • SEAT N/A
  • Revenue Next Year
  • XERS $21.09
  • SEAT $5.90
  • P/E Ratio
  • XERS N/A
  • SEAT N/A
  • Revenue Growth
  • XERS 29.88
  • SEAT 0.82
  • 52 Week Low
  • XERS $1.72
  • SEAT $1.66
  • 52 Week High
  • XERS $6.07
  • SEAT $5.90
  • Technical
  • Relative Strength Index (RSI)
  • XERS 63.30
  • SEAT 31.59
  • Support Level
  • XERS $4.26
  • SEAT $2.65
  • Resistance Level
  • XERS $4.77
  • SEAT $3.01
  • Average True Range (ATR)
  • XERS 0.28
  • SEAT 0.18
  • MACD
  • XERS 0.08
  • SEAT -0.07
  • Stochastic Oscillator
  • XERS 91.32
  • SEAT 12.59

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: